Wellgistics Health, Inc. (WGRX) Stock Analysis
Healthcare · Pharmaceutical Retailers · NasdaqCM
Wellgistics Health, Inc. (WGRX) posted $23.34M in revenue for fiscal 2025 (up 28.7% year over year), with a net loss of $101.27M, and has compounded revenue about -10.7%/yr over five years, per its SEC filings.
Data last refreshed September 3, 2026 from SEC filings · how we compute this
The analyst's take on Wellgistics Health, Inc.
Wellgistics Health, Inc. has grown revenue from $32.78M to $23.34M over the last 4 fiscal years, compounding about -10.7% a year. The most recent year was up 28.7%, so growth is actually accelerating.
Net margin sits at -433.9%, down 396.1 points year over year on a -27.5% gross margin. It carries about $23.67M of total debt.
It clears 0 of 4 deterministic health checks. The one thing worth a second look in the filings is debt with negative operating cash flow.
Synthesised from Wellgistics Health, Inc.'s SEC filings — descriptive, not advice. Ask the analyst your own question →
See a claim about Wellgistics Health, Inc.? Check it against the filing
Open the full tool →Paste a headline number you saw about WGRX — a press-release figure, a tweet, another tool’s number — and see the filed SEC number side-by-side with its source. Free, no account.
Wellgistics Health, Inc. revenue & earnings — last 4 fiscal years
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $32.78M | — | $18.13M | $23.34M |
| Gross profit | $5.75M | — | $1.77M | $-6.43M |
| Net income | $-2.74M | $-2.90M | $-6.86M | $-101.27M |
| Net margin | -8.4% | — | -37.8% | -433.9% |
Source: Wellgistics Health, Inc. SEC filings (10-K).
Wellgistics Health, Inc. financial health: 0 of 4 checks passed
- ✗Revenue CAGR over 3 yrs (-10.7%/yr)
- ✗Net margin above 10% (-433.9%)
- ✗More cash than total debt (cash 0M vs debt 34.7M)
- ✗Free cash flow positive (latest yr) (-11.7M)
Checks computed deterministically from filed annual statements — no AI judgement.
Wellgistics Health, Inc.: 2 potential red flags in the filings
Patterns in the filed statements worth a second look — computed and cited, not AI guesswork, and not a signal to sell. The kind of thing that hides in a 10-K.
- Debt with negative operating cash flowCarries $34.7M of debt while last year's operating cash flow was negative ($-10.9M).
- Currently unprofitableThe latest fiscal year was a net loss (net margin -433.9%).
Explore 4 years of Wellgistics Health, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a $24.99/month plan to track WGRX in your portfolio →
Wellgistics Health, Inc. financial history
About Wellgistics Health, Inc.
Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes branded and generic pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.
Wellgistics Health, Inc. — frequently asked questions
What is Wellgistics Health, Inc.'s revenue?
Wellgistics Health, Inc. (WGRX) reported revenue of $23.34M for fiscal year 2025, up 28.7% from the prior year, according to its SEC filings.
Is Wellgistics Health, Inc. profitable?
No — WGRX reported a net loss of $-101.27M in fiscal 2025.
How fast is Wellgistics Health, Inc. growing?
WGRX's revenue grew at roughly -10.7% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Wellgistics Health, Inc. have?
As of fiscal year 2025, WGRX carried roughly $23.67M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Wellgistics Health, Inc.'s gross margin?
WGRX's gross margin was -27.5% in fiscal 2025 — gross profit of $-6.43M on revenue of $23.34M.
What is Wellgistics Health, Inc.'s market cap?
Wellgistics Health, Inc. (WGRX) has a market capitalization of about $9.58M, based on the latest data in our nightly-refreshed cache.
When does Wellgistics Health, Inc.'s fiscal year end?
WGRX's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
Where does this data come from?
All figures are computed from Wellgistics Health, Inc.'s official SEC filings (10-K and 10-Q), covering 4 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.